MARSEILLE, France — French health authorities announced Sunday that they are monitoring a man in his late thirties who returned to metropolitan France last week exhibiting symptoms consistent with early hantavirus infection after completing a contract as a crew member aboard the research vessel Meridian Cross, the ship at the center of a hantavirus cluster in the South Pacific that has prompted alerts from international health agencies over the past two weeks. The patient is being cared for in an isolation unit at a hospital in Marseille while confirmatory laboratory tests remain pending.
The man, who has not been publicly identified in keeping with French medical privacy regulations, returned to France on May 8 following the Meridian Cross’s emergency diversion to Noumea, New Caledonia, after four crew members fell ill with febrile illness in late April. He developed a fever reaching 39.4 degrees Celsius, severe diffuse muscle aches and a persistent frontal headache within 72 hours of landing at Marseille Provence Airport, symptoms that prompted his primary care physician to order immediate hospital admission after the patient disclosed his recent travel and occupational history. Preliminary diagnostic test results were described by health officials as consistent with hantavirus exposure, though confirmatory PCR testing and full viral genome sequencing were still pending as of Sunday evening, according to a statement released by the Direction Générale de la Santé.
French health officials were careful to emphasize that person-to-person transmission of hantavirus is not a recognized feature of the pathogen under normal circumstances, meaning the patient does not pose a direct infectious risk to individuals he had contact with during his return journey or in the days following his arrival home before hospitalization. Contact tracing was nonetheless being conducted as a precautionary measure, with investigators focusing primarily on close household contacts and any medical or emergency personnel who came into contact with the patient before full isolation protocols were established. The European Centre for Disease Prevention and Control said it had been formally notified and was coordinating real-time information sharing with French authorities and the World Health Organization’s regional office.
The Meridian Cross departed the port of Auckland in late March on a scheduled six-week oceanic survey mission funded by a consortium of Pacific island marine research institutions. During a four-day operational port call in New Caledonia in mid-April, the vessel took on equipment and food supplies stored in a waterfront warehouse complex. Investigators believe rodents, most likely ship rats carrying a hantavirus strain indigenous to the New Caledonia region, may have entered the vessel’s below-deck cargo and storage areas during that port call or through adjacent warehouse access. Four crew members who worked in those spaces in the days following the port call subsequently became ill with febrile illness, with two requiring hospitalization in Noumea. Both hospitalized crew members were reported to be in stable condition as of last week, though one remained under observation in the facility’s respiratory medicine ward.
Dr. Isabelle Courtemanche, the infectious disease specialist overseeing the Marseille patient’s care, said the clinical presentation appeared consistent with the early prodromal phase of hantavirus pulmonary syndrome, characterized by a flu-like febrile period lasting several days that can precede potential cardiorespiratory deterioration in the more severe form of the illness. She said the patient’s respiratory function was being monitored closely but had not shown significant compromise as of Sunday. “We identified this case early, which gives us the best possible opportunity to manage it effectively and respond to any change in clinical status rapidly,” Dr. Courtemanche said at a brief press conference outside the hospital. “Our priority is the patient’s wellbeing, and we will keep the relevant authorities fully informed as the situation develops.”
The Meridian Cross incident has drawn fresh attention to biosecurity protocols governing research and commercial vessels transiting ports in regions where rodent-borne pathogens circulate. Maritime health specialists noted that rodent exclusion practices aboard oceangoing vessels have historically concentrated on preventing infestation during extended passages, with less systematic attention paid to the exposure risk presented by brief port calls in areas where infected rodent species are prevalent near waterfront infrastructure. The International Maritime Health Association said it would publish updated guidance on rodent surveillance procedures and biosecurity inspection protocols for vessels operating in the Pacific island region within the next 60 days.
Health authorities across continental Europe and the wider international community said there was no basis for broader public alarm arising from the Marseille case or the South Pacific cluster more generally. Unlike respiratory viruses, hantavirus requires direct contact or very close indirect contact with contaminated rodent materials for transmission to occur in humans, making community spread through ordinary social interaction or shared environments effectively impossible with known hantavirus strains. Epidemiologists noted that Europe records a small number of domestically acquired hantavirus cases each year — primarily hemorrhagic fever with renal syndrome linked to European rodent reservoirs in rural and forested areas — and that the Meridian Cross cluster, while unusual in its maritime transmission context, did not represent a novel strain or an altered pattern of transmissibility. Full genome sequencing results from samples collected aboard the vessel were anticipated within the following week and were expected to clarify the precise relationship between the shipboard cases and the symptomatic French crew member.